Anthropic CEO urges AI firms to slow model development
Anthropic CEO urges AI companies to slow model development amid AI-related fears, as part of a broader US briefing covering multiple policy, macro, energy, and corporate items.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AstraZeneca's breast cancer drug fails in late-stage trial
AstraZeneca's LSE:AZN breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial, it said on Friday, marking a setback for the recently approved treatment.U.S.-listed shares of AstraZeneca fell 3% in aftermarket trading.The drug, branded as Etca…
Astrazeneca's breast cancer drug fails late-stage trial
AstraZeneca LSE:AZN said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial.